Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single ascending dose crossover study of ASP3652 in healthy volunteers
NL-OMON37404Phase 1Active, not recruiting
- Sponsor
- Astellas Pharma
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of asp3652, sponsored by Astellas Pharma. Primary endpoint: Safety and tolerability. Started Aug 2012; status: active, not recruiting.
02
Drugs
asp3652
Beyond the preview
Go deeper on NL-OMON37404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37404.